Meet Our Leadership Team

The Healthmap team is comprised of a unique blend of clinical and patient services specialists, and technology and data analytics experts. We are led by proven senior executives, with valuable guidance from our Board of Directors and Advisory Group, who are respected healthcare industry leaders.   

Eric Reimer

Eric is a national healthcare executive with over 30 years of healthcare services experience and leadership, and over 17 years of success in growing a wide range of specialty healthcare companies which deliver sustained value to customers. Prior to joining Healthmap, Eric was an Operating Partner at private equity firm Water Street. He serves as a director of ELAP Services, Unified Physician Management, and Invo Healthcare and is the co-chairman of the Board of Healthmap Solutions.

As the former Chief Executive Officer of CareCentrix, the leader in home health benefits management, Eric led the company through its spin-off from Gentiva Health Services, broadened the management team, and introduced innovative product offerings to double the company’s contracted revenues. He also was a senior executive at Magellan Health Services. During his tenure with Magellan, he served as senior vice president of the Health Plan West Behavioral division serving 15 Blues plans, chief growth officer responsible for sales, strategy, and acquisitions, and Chief Executive Officer of National Imaging Associates (NIA), where he led the division through a two year period during which revenue grew over 8 times.

Prior to Magellan, Eric held executive positions at CIGNA, Prudential Healthcare, and the Boston Consulting Group. He was a co-founder of Internet Healthcare Group, Digital Insurance (now One Digital), and Lumenos. He previously served as director of OBHospitalist Group, Beacon Options, Triad, and Digital Insurance (now One Digital), before their successful sales to Gryphon Investors, Anthem, Medsolutions, and Fidelity National, respectively. Eric received his bachelor's degree from Washington University and a master's in business administration from the Wharton School of Business at the University of Pennsylvania.

 

Joe Vattamattam

As Chief Financial Officer and President, Joe is responsible for leading the organization to align the company’s innovative product offerings with its value proposition, culminating in high-performing risk-bearing products. As a co-founder of Healthmap, he set the strategic vision in place, leading its growth from an early-stage company to a national market leader in kidney health management.

Joe has broad and deep experience developing, underwriting, pricing, and managing value-creating healthcare programs across multiple niches within healthcare. Joe was critical to driving organic growth, product development, acquisitions, and business process improvement during his tenure as Vice President Medical Economics at CareCentrix, and as Director, Health Services at WellCare Health Plans.

Prior to WellCare, Joe was an investment banker at Wells Fargo (formerly Wachovia Securities), where he provided capital market and mergers and acquisitions advisory services to organizations in the IT Services sector.

Joe serves as a director on the board of Heritage Property and Casualty Insurance (NYSE: HRTG). He earned his undergraduate degree in mathematics from the University of Florida and his master’s in business administration from Georgetown University.

Andrew Wall

As Chief Innovation Officer, Andrew leads a team to drive product strategy and address new market opportunities. He is a co-founder of Healthmap, and his leadership, creativity, and innovative approach to problem-solving have helped the company grow from being an early-stage company to a national market leader in kidney health management. Andrew brings a blend of valuable experience to Healthmap, having served as a Chief Operating Officer and Chief Technology Officer, run growth businesses, built organizations, and developed senior leaders throughout his career. Andrew drives value through innovative technology-enabled products and services, helping payors, providers, and self-insured companies manage quality and costs while ensuring their populations receive the best healthcare outcomes.

Andrew brings to Healthmap years of diverse healthcare and technology industry experience with McKesson, Medtronic, Cleveland Clinic, Kaiser Permanente, Deloitte Consulting, and Workday, where he created innovative value-based models and technology solutions for health plans, hospital systems, and providers, including a first-of-its-kind health information exchange.

Andrew serves on the Board of Directors for the National Kidney Foundation of Florida and Mercury Specialty Network and serves as a subject matter expert for CMS / CMMI. Andrew holds a Master of Science degree from Columbia University and a Bachelor of Science degree from the Florida State University.

Tom Gaffney

As Chief Growth Officer, Tom is responsible for the company’s growth expansion strategy, client relationships, and sales and marketing. In his role, Tom aligns the company’s extensive strengths and internal resources to bring the most effective low-cost, high-quality programs to patients living with kidney disease, supports providers in practicing best-in-class, lower-cost medicine and reduces spend and trend for payors.

Tom is a nationally recognized healthcare executive with more than 25 years of experience building and leading organizations that change traditional methods of high-cost, lower-quality healthcare services. An industry trailblazer, in 2006 Gaffney founded Sleep Management Solutions (SMS), the first Sleep Benefits Management (SBM) company in the country and effectively created the Sleep Benefits Management healthcare space. Before joining Healthmap Solutions, Gaffney was the Chief Customer Officer at CareCentrix, where he managed the company’s client portfolio and Account Management functions.
 

Richard Popiel, M.D., MBA

Chief Medical Officer

Dr. Richard Popiel is a board-certified internal medicine physician and healthcare executive with over 26 years of experience leading patient-centric healthcare organizations. Throughout his career, he has used his medical and business expertise to help individuals navigate the complexities of the healthcare system while ensuring the cost of healthcare remains affordable to consumers. He is the co-founder and Managing Partner at Xploration Health, LLC, and a Senior Advisor at McKinsey & Co.

Dr. Popiel is the former Executive Vice President and Chief Medical Officer for Cambia Health Solutions, a Portland-based healthcare solutions company working to create a person-focused and economically sustainable healthcare system. Prior to joining Cambia, Dr. Popiel served as President and Chief Operating Officer of Horizon Healthcare Innovations, a Horizon BlueCross BlueShield (BCBS) of New Jersey company. Before that, he served as Horizon BCBS of New Jersey’s Vice President and Chief Medical Officer and as Vice President and Senior Medical Director for The Permanente Company, a subsidiary of Kaiser Permanente.

Dr. Popiel serves on the Boards/Advisory Boards of several healthcare organizations, including CareCentrix, Medecision, BioiQ, Tabula Rasa Healthcare, and Pager, all trailblazers in using technology and predictive analytics to seamlessly connect patients to the right care at the right time in the right place. He is also a member of the Board of The George Washington University Medical Associates, one of the largest medical groups in the District of Columbia. Dr. Popiel is a graduate of The George Washington University Medical School and received his MBA from the Kellogg School of Management at Northwestern University.

Dr. Elizabeth Prence

As Chief Clinical Quality Officer, Liz is responsible for the clinical validity of Healthmap’s products. She also guides the activities of Healthmap’s Scientific Advisory Board in the development of clinical algorithms, such as those applicable to the identification and treatment of chronically ill patients. Additionally, Liz applies her industry expertise in the areas of laboratory medicine, medical coding, translation of professional guidelines to practical implementation, quality assurance, and HIPAA compliance.

Liz brings a broad, unique perspective to the company with over 40 years of experience in health care, most of which was focused on laboratory medicine. She is board-certified in both genetics and clinical chemistry, is a Fellow of the American College of Medical Genetics and Genomics, and her experience spans commercial, academic, and non-profit settings. She has held a variety of roles in which she led the efforts of large, cross functional groups to drive organic growth through provision of high quality care. Her commercial experience includes over 11 years at Quest Diagnostics, and her academic experience includes faculty appointments at Harvard Medical School, Massachusetts General Hospital, Brandeis University, and the University of Pittsburgh, Graduate School of Public Health.

Greg Winkler

As Chief Actuary and Vice President of Medical Economics, Greg is responsible for developing effective cost-analysis reporting and utilization metrics in order to drive actionable business decisions. In this role, Greg uses his diverse healthcare background, including extensive knowledge of Medicare and Medicaid, and strategic focus to develop key performance metrics and cost savings opportunities for the organization as well as our clients.

Greg has over 20 years of experience as a healthcare actuary working in a variety of different settings with various responsibilities including product pricing, product development, risk adjustment, financial forecasting, government programs, and mergers and acquisitions. He has held various leadership roles at several large national healthcare payors, including Coventry Health Care, WellCare, Anthem BlueCross/Blue Shield and most recently was a Senior Consultant at an actuarial consulting firm specializing in Medicare bids and pricing models. Greg is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries. He holds a BS degree from Purdue University.

Ken Vida 

As Chief Technology Officer, Ken is responsible for all of the company’s technology assets.  His ability to lead, predict trends and react in real-time to the complex needs of our clients continually strengthens Healthmap Solution’s cutting-edge and highly scalable proprietary technology platform, Compass.

Ken has a diverse background including finance, healthcare, and benefit management organizations.  He has created complex role-based user interfaces, middleware components and standalone applications while implementing strategies to balance transaction speed with reliability.  Ken holds two degrees, a B.S. in Computer Sciences and a B.S. in Business Management, from Richard Stockton College of New Jersey and numerous technology-based certifications.

 

 

Kathleen Mullin 

As Chief Information Security Officer (CISO), Kathleen is responsible for establishing and maintaining the enterprise vision, strategy, and program to ensure information assets and technologies are adequately protected. Kathleen is a cyber security expert responsible for the development, implementation, and administration of security matters. Kathleen uses her passion for information security to enable Healthmap to deliver services while appropriately protecting the data of our clients.

Kathleen is an internationally recognized executive and featured speaker on Governance, Risk, and Information Security specializing in healthcare. Kathleen’s background includes serving as CISO at Adventist Health, Healthplan Services, Tampa Airport, and WageWorks, firms that are not-for-profit, private equity, governmental, or publicly traded entities.  Her memberships include Infragard, (ISC)2, and ISACA and she does volunteer work within the information security community.  She has a B.S.B.A with a concentration in accounting from St Joseph’s College Maine and an MBA from Florida Metropolitan University. Her certifications include a CISSP from (ISC)2 and a CCSFP from HITRUST.

Kisha Thompson

As Vice President of Human Resources, Kisha is responsible for providing strategic leadership and direction on all facets of HR management, as it relates to organizational development, performance management, recruiting and staffing, compensation and benefits, and employment law. Kisha applies her drive and experience to re-engineer processes and develop new procedures to maximize efficiency.

Having worked in the healthcare industry for the past 5 years, Kisha served as Head of Human Resources for Health Integrated and utilizes that knowledge to align the organization and accelerate Healthmap Solutions to the next level. She is an active member of SHRM, HR Tampa, and strives to stay current on all HR trends. Kisha holds a B.S. degree from the University of Florida.

Amy Kozsuch

As Vice President of Clinical Products, Amy is responsible for expanding and developing innovative programs that advance early detection of chronic kidney disease, defer its progression and deliver improved patient outcomes at lower costs. In this role, she integrates the kidney health, behavioral health and social determinant of health needs of patients with data and analytics, creating evidence-based personalized care plans that meet the needs of each patient.

Amy has over 20 years of experience leading clinical teams, healthcare executives and physician practices to drive positive change in care delivery systems and overall healthcare markets. She has developed and enhanced integrated networks of care, strategic alliances, physician and executive leadership relations, rural health and health education. Amy is the President of the National Kidney Foundation of Florida, past President of the Florida Renal Association and Board Member of Families with SCN2A Foundation, an organization created by parents of children diagnosed with rare forms of Epilepsy and Autism. She is a former DaVita executive in the areas of Business Development and Kidney Care. Amy earned her MSN, MBA and HCA from University of Phoenix, where she is currently a doctoral candidate.

 

Board of Directors

Steve Shulman

Mr. Shulman serves as managing partner of Shulman Family Ventures, a private equity firm since 2008. He is the former chairman and chief executive officer of Magellan Health Services (NASDAQ:MGLN), where he spearheaded the company’s successful turnaround, restructuring out of bankruptcy, and diversification into the nation’s foremost specialty healthcare managed care company. He also led Prudential Healthcare through its major turnaround while serving as the company’s chairman, president and CEO, culminating in the company’s successful sale to Aetna. Steve was also the co-founder of Value Health, Inc. (a NYSE) managed care company specializing in behavioral health and prescription drug benefit management.

Steve currently serves as the Chairman of the Board of CareCentrix (privately held post-acute managed care company) and Quartet (privately held technology company focused on the integration of behavioral and physical medicine). He also currently serves as a director of VillageMD (privately held primary care medical management company), MedImpact (largest privately held prescription drug benefits management company-PBM), Healthmarkets (privately held healthcare distribution and specialty insurance company) and Facet Technologies (privately held OEM of lancets and lancing devices for diabetics).

Steve also served as Chairman of the Board of R1 (NASDAQ) healthcare revenue cycle management company, Health Management Associates (a NYSE listed national company that owned and operated 71 hospitals), where he successfully participated in a hostile takeover and engineered its sale to CHS for $7.6 B which closed in early 2014. Mr. Shulman previously founded Internet HealthCare Group, a venture fund focused on the intersection of early stage health care and technology companies. Prior to that Steve served in senior executive positions at Cigna and Kaiser. 

Mr. Shulman’s qualifications as a director include his extensive experience in the healthcare industry, including serving as chief executive of several large healthcare sector organizations and as operating partner for a healthcare private equity firm, and his roles as a director of several privately held companies.

 

Ari Benacerraf

Ari Benacerraf is a Partner and member of the Investment Committee at Five Arrows Capital Partners, the U.S. middle-market private equity business of Rothschild Merchant Banking.

Prior to FACP, Ari co-founded Diamond Castle where he was a Partner since 2005.  He played a leadership role as part of the Diamond Castle investment team and was a member of the firm’s Investment Committee.  Ari focused primarily on the healthcare sector while at Diamond Castle.  Representative investments in the healthcare sector included Managed Health Care Associates, Inc., Beacon Health Strategies, LLC, ValueOptions, Inc., Suture Express, Inc. and Healthmap Solutions, Inc.

From 2001 to 2004, Ari served as a Managing Director at DLJ Merchant Banking Partners, where he had been a Principal and a Vice President since 1995.  Prior to DLJ, Ari served as a Vice President at Bankers Trust Company from 1992 to 1995.  Previously he was an Associate at Banque Nationale de Paris. Ari currently serves on the board of Beacon Health Options, Suture Express, Multi-Color Corp. (Nasdaq: LABL) and Healthmap Solutions. Representative prior board appointments include: Managed Health Care Associates, Inc., NES Rental Holdings, Inc. and Catamount Energy Corporation.

Ari holds a BA in Chemistry from Franklin & Marshall College and an MBA from The Johnson School of Management of Cornell University.

 

Cherrill Farnsworth

Cherrill Farnsworth is an influential national expert on changing health care regulations and an entrepreneur who has founded seven successful companies over the course of her career.

In her role as an industry expert, Farnsworth is a regular speaker at business and health care symposia and is considered a national authority on changing health care regulations. Since 1984, Ms. Farnsworth has been a regular spokesperson for radiology management and reform before the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS). She has testified on the need to regulate quality in radiology at the House Ways & Means Committee and Congress. She is also a member of the National Quality Forum (NQF), which was formed by the U.S. Senate in response to the Institute of Medicine's report on medical mistakes.

Further, Farnsworth has served on the faculties of the Radiological Society of North America (RSNA) and the American Healthcare Radiology Administrators (AHRA), and on the editorial advisory boards of Imaging Economics and Advanced Imaging. She has regularly contributed articles to health care industry publications.

In addition, Farnsworth sits on several boards, including the American Association of PPOs (AAPAN), Vital Decisions, and HealthHelp, for which she serves as the board’s chairman.

Nationally recognized for her achievements, she has received the KPMG Peat Marwick High Tech Entrepreneur of the Year Award and the Ernst & Young Entrepreneur of the Year Award. The National Association of Specialty Health Organizations has named her “Most Influential in Specialty Health.” Under her progressive leadership, HealthHelp has been named multiple times to Inc. Magazine’s list of the 5000 fastest growing private companies in the United States and to the Houston Business Journal’s Fast 100, a list of the fastest growing companies in Houston.

Texas Executive Woman named her a Woman on the Move in 1986. In 2015, she was elected to the prestigious Committee of 200, a membership organization of the world’s most successful women entrepreneurs and corporate innovators. Also, Farnsworth is an active elected member of the Women Business Leaders of the U.S. Health Care Industry Foundation.

A graduate of Butler University, Ms. Farnsworth received her degree magna cum laude and has served on the school's board of trustees.

Jonathan B. Gavras, M.D., FCCP

Dr. Jonathan Gavras is a healthcare executive focused on promoting innovative
solutions to healthcare delivery. He has held executive level positions with health plans
and pharmacy benefits management companies. His experience has given him a broad
understanding of the drivers of healthcare change and a unique strategic perspective to
a quickly evolving industry. He is currently the President of the Florida market for Bright
Health Plan.

Prior to joining Bright Health, Dr. Gavras was Senior Vice President and Chief Medical
Officer at Prime Therapeutics, where he led the specialty pharmacy efforts, which
focused extensively on the integration of medical and pharmacy drug management.
Formerly, he was President and Chief Medical Officer of Avalon Healthcare Solutions, a
comprehensive laboratory benefit management company. Dr. Gavras was a senior
executive at Florida Blue from 2006 to 2014, serving first as Senior Vice President,
Delivery System and Chief Medical Officer before becoming the first President of
Guidewell Health, a subsidiary or Florida Blue’s parent company, Guidewell. As
President of Guidewell Health, Dr. Gavras was responsible for the direct delivery of care
models within the company. Prior to joining Florida Blue, he held several senior
leadership positions at UnitedHealth Group and Prudential Healthcare respectively. Dr.
Gavras’ expertise in developing and implementing value-based care models earned him
election to the Healthcare Financing Management Association (HFMA) National Board
of Directors. His appointment to the HFMA National Board of Directors was the first
time a member was elected from a commercial insurance company.

Dr. Gavras entered his healthcare executive career after a successful clinical career in
Pulmonary Medicine. Dr. Gavras holds a BA in Chemistry and Psychology from Case
Western Reserve University and a Medical Doctor Degree from New York Medical
College.

Trent T. Haywood, M.D., J.D.

Dr. Haywood is a leading healthcare executive who has been at the forefront of the healthcare industry’s transformation to value-based care and whose expertise in developing and leading best practices to improve quality, drive clinical innovation, and eliminate social determinants of health barriers to care has earned him industry-wide recognition. He is a board-certified internal medicine physician who brings over 20 years of healthcare management experience to the Healthmap Board. Dr. Haywood is the founder of KNOWALITY, LLC a venture services firm dedicated to accelerating market adoption of innovative healthcare services and products that improve population health. 

Most recently, Dr. Haywood served as Chief Medical Officer of the Blue Cross Blue Shield (BCBS) Association where he was responsible for guiding medical policy and clinical programs for the association’s 36 member health plans. In addition, he served as President of the Blue Cross Blue Shield Institute, a benefit corporation focused on addressing the social determinants of health for BCBS plans.

Previously, Dr. Haywood led national efforts to implement value-based healthcare as Chief Medical Officer at Vizient (formerly VHA, Inc.) and Deputy Chief Medical Officer for the Centers for Medicare & Medicaid Services (CMS). He earned a medical degree from the University of Illinois at Chicago and a Juris Doctor degree from Northwestern University. Dr. Haywood is a graduate of Notre Dame University where he earned a Bachelor of Science degree. 

Oliver T. Moses

Oliver T. Moses serves as the Managing Partner of WindRose Health Investors and has spent the last 24 years as a healthcare industry investor and advisor. Prior to joining WindRose in early 2006, Mr. Moses worked in Merrill Lynch’s healthcare investment banking group where he was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies. Mr. Moses joined Merrill Lynch in 1994, and during his investment banking career, raised more than $6 billion for his clients and advised on M&A transactions with an aggregate value of $16 billion. Prior to investment banking, Mr. Moses was a healthcare-focused securities analyst in Merrill Lynch’s equity research department, where he was ranked as one of Wall Street’s “Up and Comers” by Institutional Investor’s All-America Research Team Survey.

Mr. Moses currently serves on the board of directors of basys, MDsave, myNEXUS, Shearwater Health, Trumpet Behavioral Health and Vital Decisions. Outside of his professional work, Mr. Moses serves on the board of the African Dream Academy Foundation and as a deacon of The Brick Presbyterian Church. He lives in New York City with his wife and two children.

Mr. Moses holds a Bachelor of Arts degree from Bowdoin College.

 

David Pontius


Mr. Pontius received his Bachelor of Science in Business Administration from The University of North Carolina at Chapel Hill. Prior to joining WindRose Health Investors in 2008, Mr. Pontius worked in the Healthcare Investment Banking Group of Oppenheimer & Co. (formerly CIBC World Markets), where he focused on strategic advisory, mergers and acquisitions and public and private company financings. Mr. Pontius currently serves on the board of directors of Kolmac, MDsave, Ovation Fertility, Shearwater Health, Traditions Behavioral Health, and TrustHCS.

 

 

Jacob Stark


Prior to joining WindRose Health Investors in 2016, Mr. Stark was an analyst at UBS Investment Bank in the Leveraged Finance & Financial Sponsors Group, where he focused on leveraged buyouts, restructurings, recapitalizations, and capital markets across a range of industries. Mr. Stark received his Bachelor of Arts in Economics and French from Williams College.

Our Advisors

Dr. Robert J. Cooper

Robert Cooper, MD, is attending physician in the department of endocrinology at Baystate Medical Center in Springfield, Massachusetts. Dr. Cooper received his medical degree from Albert Einstein College of Medicine, Bronx, New York, and completed residency training in internal medicine at Long Island Jewish Hospital, New Hyde Park, New York. He completed two combined years of fellowship training in endocrinology at Long Island Jewish Hospital and Winthrop–University Hospital, Mineola, New York.

Dr. Cooper specializes in all areas of endocrinology, including thyroid disorders; diabetes; adrenal, pituitary, and lipid disorders; disorders of metabolism; and osteoporosis. He is a former longstanding member of the Legislative and Regulatory Committee and also served on the Endocrine Board Review Committee of the AACE. He also has served on the Advisory Board for the Connecticut American Diabetes Association Annual Meeting since 2003, as an advisor to the Cardiometabolic Health Congress since 2005, and as Editor of MedStudy Internal Medicine Board Review since 2013.

 

Dr. James Davis

Dr. Davis received his MD from the University of Kentucky in 1999, where he graduated with distinction and was named to Alpha Omega Alpha He completed residency in medicine and pediatrics in 2003 at the University of Cincinnati. Following his renal fellowship at the University of Cincinnati, Dr. Davis went into private practice for nephrology at The Kidney and Hypertension Center, where he served on the Board of Directors for three terms. Dr. Davis is currently an Assistant Professor of Medicine, Division of Nephrology, Department of Internal Medicine, for Washington University School of Medicine.

 

Dr. Joel B. Forman

Dr. Forman is a practicing general cardiologist with interests in stress testing, echocardiography, lipidology and cardiovascular wellness.  He attended medical school at The Ohio State University and completed his internal medicine residency at Emory University with subsequent cardiovascular disease training at The Medical College of Virginia/ Virginia Commonwealth University.  Along with advisory and consultative roles, he comes to Healthmap with years of patient centered experience.    A primary goal is using the knowledge and tools of a busy clinician applied to technology and data, thereby promoting wellness in an even larger population of at risk individuals.

Dr. Thomas D. Nolin

Dr. Thomas Nolin is a tenured Associate Professor in the Department of Pharmacy & Therapeutics, and in the Department of Medicine Renal-Electrolyte Division at the University of Pittsburgh. His primary research focuses on developing an understanding of the impact of kidney disease and renal replacement therapy (RRT) on nonrenal metabolism and transport pathways and corresponding effects on drug exposure and response. Dr. Nolin has a strong record of interdisciplinary and interinstitutional collaborations with regulatory, pharmaceutical industry, and academic scientists in the conduct of a broad range of clinical-translational studies in patients with kidney disease. He served as chair of the Kidney Health Initiative workgroup to assess pharmacokinetics during RRT and as co-chair of the Extracorporeal Treatments in Poisoning (EXTRIP) Workgroup. Dr. Nolin has published over 120 manuscripts and book chapters and has presented more than 140 scientific abstracts and invited talks. He serves on the editorial board of the American Journal of Kidney Diseases, the Clinical Journal of the American Society of Nephrology, and as an Editor of the textbook Pharmacotherapy: A Pathophysiological Approach. Dr. Nolin is a Fellow of the American College of Clinical Pharmacy, the American College of Clinical Pharmacology, and of the American Society of Nephrology.

Dr. Nolin holds a B.S. in Pharmacy from the University of Connecticut, a M.S. in Pharmacy from the University of North Carolina, and Pharm.D. and Ph.D. degrees from the University of Pittsburgh.

 

Andrew D. Sherman


Mr. Sherman is currently the Chief Development Officer for Women's Care Enterprises, a leading multi-specialty provider of women's health services. Mr. Sherman also currently serves on the Board of KBL Merger Corp IV (NASDAQ:KBLM), a healthcare-focused special purpose acquisition corporation fund that went public in 2017 and Kolea Healthcare, a privately held home health company. Prior to Women's Care Enterprises, Mr. Sherman led corporate development for Unified Physician Management and previously was a Partner at DCH Partners, a healthcare-focused private equity firm focused on transaction development.

Mr. Sherman brings 25 years in investment banking, M&A and private equity to the advisory board having completed over 100 M&A and private equity transactions including over $35 billion in M&A transactions. Mr. Sherman holds a B.S. in Economics and Finance from The Wharton School of Business, a B.A. in International Relations from the University of Pennsylvania, and an M.B.A. with Distinction from The Harvard Graduate School of Business Administration.

 

Tom Warnes, PhD

As Clinical Program Architect, Dr. Warnes is responsible for leading the design of Healthmap’s current and future care management programs. Tom brings 25 years of valuable experience to Healthmap, having run large medical management divisions within the health plan, specialty benefit management, and health system space. A trained clinical psychologist, he brought his clinical expertise as a provider to the design and management of innovative clinical programs that improve quality and lower total health care costs. He has held senior executive positions within several large organizations, including WellCare, MunichRe, CHI hospital systems, and CareCentrix. Tom holds a BS, Chemistry degree from Michigan State University, and a PhD, Psychology degree from Southern California University.